Literature DB >> 31245074

Local control of locally advanced (N2) non-small cell lung cancer: when and how?

Byung Jo Park1, Jhingook Kim1.   

Abstract

Entities:  

Year:  2019        PMID： 31245074      PMCID： PMC6560564          DOI： 10.21037/jtd.2019.04.26

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

Review 1.  Multimodality treatment of stage IIIA non-small-cell lung carcinoma: a critical review of the literature and strategies for future research.

Authors:  G M Strauss; M P Langer; A D Elias; A T Skarin; D J Sugarbaker
Journal:  J Clin Oncol       Date:  1992-05       Impact factor: 44.544

Review 2.  Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.

Authors:  Francesca Soldà; Mark Lodge; Sue Ashley; Alastair Whitington; Peter Goldstraw; Michael Brada
Journal:  Radiother Oncol       Date:  2013-10-12       Impact factor: 6.280

3.  Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.

Authors:  R Rosell; J Gómez-Codina; C Camps; J Javier Sánchez; J Maestre; J Padilla; A Cantó; A Abad; J Roig
Journal:  Lung Cancer       Date:  1999-10       Impact factor: 5.705

4.  Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature.

Authors:  T Berghmans; M Paesmans; A P Meert; C Mascaux; P Lothaire; J J Lafitte; J P Sculier
Journal:  Lung Cancer       Date:  2005-07       Impact factor: 5.705

5.  Long-term survival of patients with pN2 lung cancer according to the pattern of lymphatic spread.

Authors:  Antoine Legras; Pierre Mordant; Alex Arame; Christophe Foucault; Antoine Dujon; Françoise Le Pimpec Barthes; Marc Riquet
Journal:  Ann Thorac Surg       Date:  2014-02-26       Impact factor: 4.330

6.  Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

Authors:  Paul De Leyn; Christophe Dooms; Jaroslaw Kuzdzal; Didier Lardinois; Bernward Passlick; Ramon Rami-Porta; Akif Turna; Paul Van Schil; Frederico Venuta; David Waller; Walter Weder; Marcin Zielinski
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-26       Impact factor: 4.191

7.  Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.

Authors:  Hong Kwan Kim; Jong Ho Cho; Yong Soo Choi; Jae Ill Zo; Young Mog Shim; Keunchil Park; Myung-Ju Ahn; Yong Chan Ahn; Kwhanmien Kim; Jhingook Kim
Journal:  Lung Cancer       Date:  2016-03-29       Impact factor: 5.705

8.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

Review 9.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

Authors:  Hisao Asamura; Kari Chansky; John Crowley; Peter Goldstraw; Valerie W Rusch; Johan F Vansteenkiste; Hirokazu Watanabe; Yi-Long Wu; Marcin Zielinski; David Ball; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

Review 10.  A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer.

Authors:  Sarah Burdett; Lesley A Stewart; Larysa Rydzewska
Journal:  J Thorac Oncol       Date:  2006-09       Impact factor: 15.609
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.